Generic approved as part of combination regimens for active and latent pulmonary TB

The FDA announced approval of generic Priftin tablets to treat two types of tuberculosis caused by Mycobacterium tuberculosis, marking the first generic of this drug, according to…

Generic approved as part of combination regimens for active and latent pulmonary TB